Natlawreview iconNatlawreviewSep 17, 2026 ~1 min source read

Feature — Top Intelligence Provider for Investment Banks and Corporate Law Firms Predicts Signals for Deal Makers: Healthcare & Life Sciences Deal Predictions (September 8, 202...

Between May 18 and September 8, 2026, Fintent flagged 43 healthcare and life sciences transactions before they were announced. The lead times are floors too — signal history for this cohort begins in mid-2024, so a deal announced in mid-2026 cannot show more than about 24 months of runway even if the runway was longer.

Feature — Top Intelligence Provider for Investment Banks and Corporate Law Firms Predicts Signals for Deal Makers: Healthcare & Life Sciences Deal Predictions (September 8, 202...

Share this story

Send the public story page.

Useful takeaways from this story.

Between May 18 and September 8, 2026, Fintent flagged 43 healthcare and life sciences transactions before they were announced.

The lead times are floors too — signal history for this cohort begins in mid-2024, so a deal announced in mid-2026 cannot show more than about 24 months of runway even if the runway was longer.

Ten of the 43, chosen for lead time, signal richness and buyers you will recognise.

Building the complete brief

The page is ready to read now. The fuller skim-friendly version will appear here automatically.

The useful part

Between May 18 and September 8, 2026, Fintent flagged 43 healthcare and life sciences transactions before they were announced. The lead times are floors too — signal history for this cohort begins in mid-2024, so a deal announced in mid-2026 cannot show more than about 24 months of runway even if the runway was longer. Ten of the 43, chosen for lead time, signal richness and buyers you will recognise.

How it works

  • Company Acquirer Announced Signal Detected Intent Signals Lead Time Bio-Techne <...

Details worth keeping

In each case the behaviour that precedes a process was observable in 2024. Which healthcare deals did Fintent call before they were announced? Eli Lilly's acquisition of Curevo Vaccine for up to $1.5 billion (investor.lilly.com), Tempus's roughly $1.5 billion acquisition of the genomic diagnostics business Personalis (investors.tempus.com), and The Oregon Clinic's absorption of the independent Portland primary-care practice Broadway Medical Clinic (oregonclinic.com).

Keep reading in the app

Open the app view to save this story, compare related coverage, and continue from the same source.

Open in app